E83

Disorders of mineral metabolism, not elsewhere classified

## Overview of Disorders of Mineral Metabolism, Not Elsewhere Classified This ICD-10 category, E83, encompasses a broad range of conditions characterized by disturbances in the body's balance and processing of essential minerals, excluding those specifically classified elsewhere. Minerals are inorganic elements vital for numerous physiological functions, including bone formation, nerve transmission, muscle contraction, enzyme activity, fluid balance, and hormone production. When the metabolism of these minerals is disrupted, either due to deficiency, excess, or impaired utilization, it can lead to a wide array of clinical manifestations affecting almost every organ system. ### Importance of Mineral Homeostasis Mineral homeostasis is a tightly regulated process involving complex interactions between dietary intake, absorption in the gastrointestinal tract, distribution within tissues, storage, and excretion by the kidneys. Key regulatory hormones, such as parathyroid hormone, calcitonin, and vitamin D, play crucial roles in maintaining optimal levels of minerals like calcium and phosphorus. Other minerals, including magnesium, potassium, sodium, iron, zinc, copper, and selenium, also have intricate regulatory mechanisms. ### General Classification Disorders within this category can arise from: * **Deficiencies:** Insufficient intake, malabsorption, or excessive loss leading to inadequate body stores. * **Excesses (Toxicities):** Over-ingestion, impaired excretion, or abnormal storage leading to harmful accumulation. * **Impaired Metabolism/Utilization:** Genetic defects or acquired conditions affecting the transport, activation, or utilization of minerals at the cellular level. Given the critical roles of minerals, these disorders can impact endocrine function, skeletal health, cardiovascular system, nervous system, renal function, and overall cellular integrity. Accurate diagnosis often requires careful clinical evaluation, detailed dietary history, and specific laboratory tests to measure serum and urinary mineral levels, along with relevant hormonal markers.

Clinical Symptoms

  • Fatigue and weakness
  • Muscle cramps, spasms, or tetany
  • Bone pain, fractures, or deformities (e.g., osteoporosis, rickets, osteomalacia)
  • Neurological symptoms (e.g., confusion, seizures, paresthesias, behavioral changes)
  • Cardiac arrhythmias or palpitations
  • Growth retardation in children
  • Gastrointestinal disturbances (e.g., nausea, vomiting, abdominal pain)
  • Kidney stones or impaired renal function
  • Skin and hair abnormalities
  • Anemia (e.g., due to iron or copper deficiency)
  • Impaired immune function

Common Causes

  • **Genetic Predisposition:** Inherited disorders affecting mineral transport proteins, enzymes, or regulatory hormones (e.g., hereditary hemochromatosis, Wilson's disease, X-linked hypophosphatemic rickets). **Dietary Factors:** Insufficient or excessive intake of specific minerals through diet or supplements. **Malabsorption Syndromes:** Conditions like celiac disease, Crohn's disease, cystic fibrosis, or bariatric surgery that impair nutrient absorption in the gut. **Kidney Disease:** Chronic kidney disease can impair the excretion of certain minerals or the reabsorption of others, leading to imbalances (e.g., hyperphosphatemia, hypocalcemia). **Endocrine Disorders:** Conditions affecting glands that regulate mineral metabolism, such as parathyroid disorders (hyperparathyroidism, hypoparathyroidism), thyroid disorders, or adrenal insufficiency. **Medications:** Certain drugs can interfere with mineral absorption, excretion, or metabolism (e.g., diuretics, proton pump inhibitors, antacids, chemotherapy agents). **Excessive Losses:** Chronic diarrhea, excessive sweating, vomiting, or conditions causing increased urinary excretion. **Liver Disease:** Impaired liver function can affect the metabolism of certain vitamins (e.g., vitamin D) and minerals, and lead to accumulation of others (e.g., copper in Wilson's disease).

Documentation & Coding Tips

Always specify the exact mineral involved and the nature of the metabolic disorder (e.g., deficiency, excess, impaired metabolism). Avoid using E83 if a more specific code (e.g., E83.50 for unspecified disorder of magnesium metabolism) is available.

Example: POOR: Patient presents with fatigue and muscle cramps, diagnosed with mineral metabolism disorder. Patient instructed to take supplements. IMPROVED: Patient, a 68-year-old male with a history of chronic kidney disease (CKD) stage 3, presents with persistent fatigue, muscle weakness, and occasional cramps. Lab results show ionized calcium of 7.2 mg/dL (low) and serum magnesium of 1.1 mEq/L (low). Despite previous magnesium supplementation, levels remain suboptimal. Assessment: Symptomatic Hypocalcemia (E83.51) and Chronic Hypomagnesemia (E83.52) secondary to CKD. Plan: Initiate Calcium Carbonate 500mg BID and adjust Magnesium Oxide to 400mg daily. Closely monitor electrolyte levels. Education provided on dietary sources and warning signs. Patient is stable for discharge. This comprehensive documentation clearly identifies both specific mineral imbalances. Billing Focus: Clearly states specific mineral disorders (hypocalcemia, hypomagnesemia) rather than the non-specific E83, which supports higher specificity coding (E83.51, E83.52). Laterality not applicable. Risk Adjustment: Links mineral disorders to chronic kidney disease (CKD stage 3, N18.3), establishing chronicity and severity. Symptoms (fatigue, muscle weakness, cramps) further support medical necessity and patient complexity, contributing to potential HCC factors related to CKD and chronic conditions.

Billing Focus: Specificity of the mineral (e.g., calcium, magnesium, phosphorus) and the type of disorder (e.g., hypocalcemia, hyperphosphatemia). Avoid 'unspecified' if possible. Linking to underlying conditions is crucial.

Document the underlying cause or contributing factors of the mineral metabolism disorder, as well as any clinical manifestations, complications, and management plan.

Example: POOR: Patient with mineral disorder, no specific cause identified. Follow up in 3 months. IMPROVED: 55-year-old female with history of Crohn's disease (K50.90) and recent ileal resection presents with complaints of numbness, tingling in extremities, and recurrent muscle spasms. Labs reveal persistently low serum calcium (total 7.0 mg/dL, ionized 3.5 mg/dL) and low 25-hydroxyvitamin D (10 ng/mL). She also reports increased fatigue. Assessment: Hypocalcemia (E83.51) and Vitamin D deficiency (E55.9) secondary to malabsorption post-ileal resection due to Crohn's disease. The patient is also exhibiting symptoms of paresthesia and muscle spasms, indicative of the severity of hypocalcemia. Plan: Initiate high-dose Vitamin D supplementation (50,000 IU weekly x 8 weeks), Calcitriol 0.25 mcg daily, and Calcium Citrate 1000mg BID. Nutritional counseling for malabsorption. Follow up in 4 weeks for repeat labs. Billing Focus: Explicitly links hypocalcemia and Vitamin D deficiency to the underlying Crohn's disease and malabsorption (K50.90, E83.51, E55.9), providing medical necessity for lab monitoring and treatment. Specifies symptoms (numbness, tingling, spasms) and severity. Risk Adjustment: Crohn's disease is an HCC. Documenting secondary hypocalcemia and Vitamin D deficiency as complications directly resulting from her chronic condition (Crohn's) and its treatment (ileal resection) enhances the risk adjustment profile, reflecting increased disease burden and resource utilization. The chronicity and current symptomatic state are well-documented.

Billing Focus: Identify the primary diagnosis responsible for the mineral disorder or any related complications. Specificity for secondary conditions (e.g., 'hypocalcemia due to parathyroidectomy').

Relevant CPT Codes

Related Diagnoses

Hierarchy